Uromodulin biology and pathophysiology - An update

Kidney and Blood Pressure Research

Volumn 33, Issue 6, 2010, Pages 456-475

  Vyletal, Petr ^a,b   Bleyer, Anthony J ^c   Kmoch, Stanislav ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague and General University Hospital in Prague   (Czech Republic)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Determination; Hyperuricemia; Kidney; Loop of Henle; Nephropathy; Tamm Horsfall protein; UMOD; Urine; Uromodulin

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1BETA; RENIN; TAMM HORSFALL GLYCOPROTEIN;

APICAL MEMBRANE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; CHRONIC KIDNEY DISEASE; GENE MUTATION; GENETIC DISORDER; HENLE LOOP; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; URIC ACID NEPHROPATHY; URINARY EXCRETION; URINARY TRACT INFECTION;

ANIMALS; HUMANS; HYPERURICEMIA; KIDNEY DISEASES; MUTATION; UROMODULIN;

EID: 78649327296     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321013     Document Type: Review

References (301)

1. Rindler MJ, Naik SS, Li N, Hoops TC, Peraldi MN: Uromodulin (Tamm-Horsfall glycoprotein/ uromucoid) is a phosphatidylinositol-linked membrane protein. J Biol Chem 1990; 265: 20784-20789.
2. Serafini-Cessi F, Malagolini N, Hoops TC, Rindler MJ: Biosynthesis and oligosaccharide processing of human Tamm-Horsfall glycoprotein permanently expressed in HeLa cells. Biochem Biophys Res Commun 1993; 194: 784-790.
3. Kreft B, Jabs WJ, Laskay T, Klinger M, Solbach W, Kumar S, van Zandbergen G: Polarized expression of Tamm-Horsfall protein by renal tubular epithelial cells activates human granulocytes. Infect Immun 2002; 70: 2650-2656.
4. Cavallone D, Malagolini N, Serafini-Cessi F: Mechanism of release of urinary Tamm-Horsfall glycoprotein from the kidney GPIanchored counterpart. Biochem Biophys Res Commun 2001; 280: 110-114.
5. Fukuoka S, Kobayashi K: Analysis of the C-terminal structure of urinary Tamm-Horsfall protein reveals that the release of the glycosyl phosphatidylinositol-anchored counterpart from the kidney occurs by phenylalanine-specific proteolysis. Biochem Biophys Res Commun 2001; 289: 1044-1048.
6. Santambrogio S, Cattaneo A, Bernascone I, Schwend T, Jovine L, Bachi A, Rampoldi L: Urinary uromodulin carries an intact ZP domain generated by a conserved C-terminal proteolytic cleavage. Biochem Biophys Res Commun 2008; 370: 410-413.
7. Kumar S, Muchmore A: Tamm-Horsfall protein-uromodulin (1950-1990). Kidney Int 1990; 37: 1395-1401.
8. Cohen AH: Morphology of renal tubular hyaline casts. Lab Invest 1981; 44: 280-287.
9. Wenk RE, Bhagavan BS, Rudert J: Tamm-Horsfall uromucoprotein and the pathogenesis of casts, reflux nephropathy, and nephritides. Pathobiol Annu 1981; 11: 229-257.
10. Fairley JK, Owen JE, Birch DF: Protein composition of urinary casts from healthy subjects and patients with glomerulonephritis. Br Med J (Clin Res Ed) 1983; 287: 1838-1840.
11. Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, Shirts B, Xu L, Zhu H, Barmada MM, Bleyer AJ: Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 2002; 39: 882-892.
12. Turner JJ, Stacey JM, Harding B, Kotanko P, Lhotta K, Puig JG, Roberts I, Torres RJ, Thakker RV: UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy. J Clin Endocrinol Metab 2003; 88: 1398-1401.
13. Kottgen A, Glazer NL, Dehghan A, Hwang S-J, Katz R, Li M, Yang Q, Gudnason V, Launer LJ, Harris TB, Smith AV, Arking DE, Astor BC, Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Ida Chen Y-D, de Boer IH, Haritunians T, Lumley T, Sarnak M, Siscovick D, Benjamin EJ, Levy D, Upadhyay A, Aulchenko YS, Hofman A, Rivadeneira F, Uitterlinden AG, van Duijn CM, Chasman DI, Pare G, Ridker PM, Kao WHL, Witteman JC, Coresh J, Shlipak MG, Fox CS: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009; 41: 712-717.
14. Kottgen A, Hwang SJ, Larson MG, Van Eyk JE, Fu Q, Benjamin EJ, Dehghan A, Glazer NL, Kao WH, Harris TB, Gudnason V, Shlipak MG, Yang Q, Coresh J, Levy D, Fox CS: Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol 2010; 21: 337-344.
15. Drube J, Schiffer E, Mischak H, Kemper MJ, Neuhaus T, Pape L, Lichtinghagen R, Ehrich JH: Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol Dial Transplant 2009; 24: 2161-2169.
16. Kistler AD, Mischak H, Poster D, Dakna M, Wuthrich RP, Serra AL: Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int 2009; 76: 89-96.
17. Lapolla A, Seraglia R, Molin L, Williams K, Cosma C, Reitano R, Sechi A, Ragazzi E, Traldi P: Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study. J Mass Spectrom 2009; 44: 419-425.
18. Quintana LF, Campistol JM, Alcolea MP, Banon-Maneus E, Sol-Gonzalez A, Cutillas PR: Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics 2009; 8: 1658-1673.
19. Rossing K, Mischak H, Parving HH, Christensen PK, Walden M, Hillmann M, Kaiser T: Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int 2005; 68: 193-205.
20. Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X: Identification of a uromodulin fragment for diagnosis of IgA nephropathy. Rapid Commun Mass Spectrom 2010; 24: 1971-1978.
21. Ling XB, Sigdel TK, Lau K, Ying L, Lau I, Schilling J, Sarwal MM: Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol 2010; 21: 646-653.
22. Sigdel TK, Kaushal A, Gritsenko M, Norbeck AD, Qian WJ, Xiao W, Camp DG, Smith RD, Sarwal MM: Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin Appl 2010; 4: 32-47.
23. Tamm I, Horsfall FL Jr: Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med 1950; 74: 106-108.
24. Tamm I, Horsfall FL Jr: A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses. J Exp Med 1952; 95: 71-97.
25. Gottschalk A: Carbohydrate residue of a urine mucoprotein inhibiting influenza virus haemagglutination. Nature 1952; 170: 662-663.
26. Maxfield M: Physicochemical study in water of a mucoprotein with virus-inhibiting activity. Science 1958; 128: 1087-1088.
27. Odin L: Carbohydrate residue of a urine mucoprotein inhibiting influenza virus hemagglutination. Nature 1952; 170: 663-664.
28. Porter KR, Tamm I: Direct visualization of a mucoprotein component of urine. J Biol Chem 1955; 212: 135-140.
29. Tamm I, Bugher JC, Horsfall FL, Jr: Ultracentrifugation studies of a urinary mucoprotein which reacts with various viruses. J Biol Chem 1955; 212: 125-133.
30. Curtain CC: The viscometric behaviour of a mucoprotein isolated from human urine. Aust J Exp Biol Med Sci 1953; 31: 255-265.
31. Bayer ME: An electron microscope examination of urinary mucoprotein and its interaction with influenza virus. J Cell Biol 1964; 21: 265-274.
32. Bettelheim FA: Physical chemistry of mucins. Ann NY Acad Sci 1963; 106: 247-258.
33. Friedmann T, Johnson P: Further characterization of the subunit of Tamm-Horsfall mucoprotein. Biochim Biophys Acta 1966; 130: 355-360.
34. Friedmann T, Johnson P: The disaggregation of Tamm Horsfall mucroprotein by acetic acid. Biochim Biophys Acta 1966; 121: 292-297.
35. King JS Jr, Fielden ML, Boyce WH: Total nondialyzable solids in human urine. XI. Chemical analysis of purified normal uromucoid. Arch Biochem Biophys 1961; 95: 424-427.
36. Maxfield M: Molecular forms of human urinary mucoprotein present under physiological conditions. Biochim Biophys Acta 1961; 49: 548-558.
37. Maxfield M, Stefanye D: The amino acid composition of normal human urinary mucoprotein. J Biol Chem 1962; 237: 2522-2524.
38. Stevenson FK: The viscosity of Tamm-Horsfall mucoprotein. Biochim Biophys Acta 1968; 160: 296-298.
39. Rozenfel'd EL, Iusipova NA: A study of composition and properties of Tamm-Horsefall glycoprotein (in Russian). Biokhimiia 1967; 32: 111-118.
40. Schwartz RH, Pallavicini JC: Immunologic and chemical studies of cystic fibrosis and normal urinary glycoprotein of Tamm and Horsfall. J Lab Clin Med 1967; 70: 725-735.
41. Fletcher AP, McLaughlin JE, Ratcliffe WA, Woods DA: The chemical composition and electron microscopic appearance of a protein derived from urinary casts. Biochim Biophys Acta 1970; 214: 299-308.
42. Fletcher AP, Neuberger A, Ratcliffe WA: Tamm-Horsfall urinary glycoprotein. The subunit structure. Biochem J 1970; 120: 425-432.
43. Fletcher AP, Neuberger A, Ratcliffe WA: Tamm-Horsfall urinary glycoprotein. The chemical composition. Biochem J 1970; 120: 417-424.
44. Oliver CJ, Pike ER, Cleave AJ, Peacocke AR: Determination of the diffusion coefficient and molecular weight of Tamm-Horsfall glycoprotein by intensity fluctuation spectroscopy. Biopolymers 1971; 10: 1731-1733.
45. Stevenson FK, Kent PW: Subunits of Tamm-Horsfall glycoprotein. Biochem J 1970; 116: 791-796.
46. Jovine L, Qi H, Williams Z, Litscher E, Wassarman PM: The ZP domain is a conserved module for polymerization of extracellular proteins. Nat Cell Biol 2002; 4: 457-461.
47. Wiggins RC: Uromucoid (Tamm-Horsfall glycoprotein) forms different polymeric arrangements on a filter surface under different physicochemical conditions. Clin Chim Acta 1987; 162: 329-340.
48. Monis B, Gomez A, Candiotti A, Ibenez N: The Tamm-Horsfall glycoprotein and the urinary system. Electrophoretic and electron microscopic observations. Life Sci II 1972; 11: 699-708.
49. McQueen EG, Engel GB: Factors determining the aggregation of urinary mucoprotein. J Clin Pathol 1966; 19: 392-396.
50. Jovine L, Janssen WG, Litscher ES, Wassarman PM: The PLAC1-homology region of the ZP domain is sufficient for protein polymerisation. BMC Biochem 2006; 7: 11.
51. Schaeffer C, Santambrogio S, Perucca S, Casari G, Rampoldi L: Analysis of uromodulin polymerization provides new insights into the mechanisms regulating ZP domainmediated protein assembly. Mol Biol Cell 2009; 20: 589-599.
52. Dawnay AB, Thornley C, Cattell WR: An improved radioimmunoassay for urinary Tamm-Horsfall glycoprotein. Investigation and resolution of factors affecting its quantification. Biochem J 1982; 206: 461-465.
53. Cornelius CE, Pangborn J, Heckly RJ: Isolation and characterization of a urinary mucoprotein from ovine urine. Arch Biochem Biophys 1963; 101: 403-408.
54. Marr AM, Neuberger A, Ratcliffe WA: Rabbit Tamm-Horsfall urinary glycoprotein. Chemical composition and subunit structure. Biochem J 1971; 122: 623-631.
55. van Dijk W, Lasthuis AM, Ferwerda W: Preparation and chemical characterisation of calf Tamm-Horsfall glycoprotein. Biochim Biophys Acta 1979; 584: 121-128.
56. Wallace AC, Nairn RC: Tamm-Horsfall protein in kidneys of human embryos and foreign species. Pathology 1971; 3: 303-310.
57. Dunstan DR, Grant AM, Marshall RD, Neuberger A: A protein, immunologically similar to Tamm-Horsfall glycoprotein, produced by cultured baby hamster kidney cells. Proc R Soc Lond B Biol Sci 1974; 186: 297-316.
58. Muchmore AV, Decker JM: Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women. Science 1985; 229: 479-481.
59. Muchmore AV: Uromodulin: an immunoregulatory glycoprotein isolated from pregnancy urine that binds to and regulates the activity of interleukin 1. Am J Reprod Immunol Microbiol 1986; 11: 89-93.
60. Muchmore AV, Decker JM: Uromodulin. An immunosuppressive 85-kilodalton glycoprotein isolated from human pregnancy urine is a high affinity ligand for recombinant interleukin 1 alpha. J Biol Chem 1986; 261: 13404-13407.
61. Brown KM, Muchmore AV, Rosenstreich DL: Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1. Proc Natl Acad Sci USA 1986; 83: 9119-9123.
62. Muchmore AV, Decker JM: Evidence that recombinant IL 1 alpha exhibits lectin-like specificity and binds to homogeneous uromodulin via N-linked oligosaccharides. J Immunol 1987; 138: 2541-2546.
63. Muchmore AV, Shifrin S, Decker JM: In vitro evidence that carbohydrate moieties derived from uromodulin, an 85,000 dalton immunosuppressive glycoprotein isolated from human pregnancy urine, are immunosuppressive in the absence of intact protein. J Immunol 1987; 138: 2547-2553.
64. Pennica D, Kohr WJ, Kuang WJ, Glaister D, Aggarwal BB, Chen EY, Goeddel DV: Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein. Science 1987; 236: 83-88.
65. Zhu X, Cheng J, Gao J, Lepor H, Zhang ZT, Pak J, Wu XR: Isolation of mouse THP gene promoter and demonstration of its kidneyspecific activity in transgenic mice. Am J Physiol Renal Physiol 2002; 282:F608-F617.
66. Kim HT, Song IY, Piedrahita J: Kidney-specific activity of the bovine uromodulin promoter. Transgenic Res 2003; 12: 191-201.
67. Huang YJ, Chretien N, Bilodeau AS, Zhou JF, Lazaris A, Karatzas CN: Goat uromodulin promoter directs kidney-specific expression of GFP gene in transgenic mice. BMC Biotechnol 2005; 5: 9.
68. Zbikowska HM, Soukhareva N, Behnam R, Chang R, Drews R, Lubon H, Hammond D, Soukharev S: The use of the uromodulin promoter to target production of recombinant proteins into urine of transgenic animals. Transgenic Res 2002; 11: 425-435.
69. Hamlin LM, Fish WW: Physical properties of Tamm-Horsfall glycoprotein and its glycopolypeptide. Int J Pept Protein Res 1977; 10: 270-276.
70. Rampoldi L, Caridi G, Santon D, Boaretto F, Bernascone I, Lamorte G, Tardanico R, Dagnino M, Colussi G, Scolari F, Ghiggeri GM, Amoroso A, Casari G: Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. Hum Mol Genet 2003; 12: 3369-3384.
71. Tinschert S, Ruf N, Bernascone I, Sacherer K, Lamorte G, Neumayer HH, Nurnberg P, Luft FC, Rampoldi L: Functional consequences of a novel uromodulin mutation in a family with familial juvenile hyperuricaemic nephropathy. Nephrol Dial Transplant 2004; 19: 3150-3154.
72. Scolari F, Caridi G, Rampoldi L, Tardanico R, Izzi C, Pirulli D, Amoroso A, Casari G, Ghiggeri GM: Uromodulin storage diseases: clinical aspects and mechanisms. Am J Kidney Dis 2004; 44: 987-999.
73. Lens XM, Banet JF, Outeda P, Barrio-Lucia V: A novel pattern of mutation in uromodulin disorders: autosomal dominant medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, and autosomal dominant glomerulocystic kidney disease. Am J Kidney Dis 2005; 46: 52-57.
74. Yang H, Wu C, Zhao S, Guo J: Identification and characterization of D8C, a novel domain present in liver-specific LZP, uromodulin and glycoprotein 2, mutated in familial juvenile hyperuricaemic nephropathy. FEBS Lett 2004; 578: 236-238.
75. van Rooijen JJ, Voskamp AF, Kamerling JP, Vliegenthart JF: Glycosylation sites and sitespecific glycosylation in human Tamm-Horsfall glycoprotein. Glycobiology 1999; 9: 21-30.
76. Brown DA, Rose JK: Sorting of GPIanchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992; 68: 533-544.
77. Benting JH, Rietveld AG, Simons K: N-Glycans mediate the apical sorting of a GPI-anchored, raft-associated protein in Madin-Darby canine kidney cells. J Cell Biol 1999; 146: 313-320.
78. Hoyer JR, Sisson SP, Vernier RL: Tamm-Horsfall glycoprotein: ultrastructural immunoperoxidase localization in rat kidney.Lab Invest 1979; 41: 168-173.
79. Gokhale JA, McKee MD, Khan SR: Immunocytochemical localization of Tamm-Horsfall protein in the kidneys of normal and nephrolithic rats. Urol Res 1996; 24: 201-209.
80. Vylet'al P, Hulkova H, Zivna M, Berna L, Novak P, Elleder M, Kmoch S: Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy. J Inherit Metab Dis 2008; 31: 508-517.
81. Kumar S, Jasani B, Hunt JS, Moffat DB, Asscher AW: A system for accurate immunolocalization of Tamm-Horsfall protein in renal biopsies. Histochem J 1985; 17: 1251-1258.
82. McKenzie JK, McQueen EG: Immunofluorescent localization of Tamm-Horsfall mucoprotein in human kidney. J Clin Pathol 1969; 22: 334-339.
83. Pollak VE, Arbel C: The distribution of Tamm Horsfall mucoprotein (uromucoid) in the human nephron. Nephron 1969; 6: 667-672.
84. Schenk EA, Schwartz RH, Lewis RA: Tamm-Horsfall mucoprotein. I. Localization in the kidney. Lab Invest 1971; 25: 92-95.
85. Sikri KL, Foster CL, MacHugh N, Marshall RD: Localization of Tamm-Horsfall glycoprotein in the human kidney using immuno-fluorescence and immuno-electron microscopical techniques. J Anat 1981; 132: 597-605.
86. Friedman T: Immunofluorescent localization of Tamm-Horsfall mucoprotein. Experientia 1966; 22: 624-625.
87. Bichler KH, Ideler V, Harzmann R: Uromucoid excretion in normal individuals and stone formers. Curr Probl Clin Biochem 1979: 309-324.
88. Peach RJ, Day WA, Ellingsen PJ, McGiven AR: Ultrastructural localization of Tamm-Horsfall protein in human kidney using immunogold electron microscopy. Histochem J 1988; 20: 156-164.
89. Hoyer JR, Sisson SP, Vernier RL: Immunoelectron microscopical localization of Tamm-Horsfall protein (THP) in rat kidney. Federation Proceedings 1978; 37: 837.
90. Bachmann S, Koeppen-Hagemann I, Kriz W: Ultrastructural localization of Tamm-Horsfall glycoprotein (THP) in rat kidney as revealed by protein A-gold immunocytochemistry. Histochemistry 1985; 83: 531-538.
91. Jennings P, Aydin S, Kotanko P, Lechner J, Lhotta K, Williams S, Thakker RV, Pfaller W: Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy. J Am Soc Nephrol 2007; 18: 264-273.
92. Dawnay A, McLean C, Cattell WR: The development of a radioimmunoassay for Tamm-Horsfall glycoprotein in serum. Biochem J 1980; 185: 679-687.
93. Serafini-Cessi F, Bellabarba G, Malagolini N, Dall'Olio F: Rapid isolation of Tamm-Horsfall glycoprotein (uromodulin) from human urine. J Immunol Methods 1989; 120: 185-189.
94. Shenoi J, Kurien BT, Kurono S, Mascarenhas R, Matsumoto H, Scofield RH: Cost-benefit analysis of a method using diatomaceous earth to purify Tamm-Horsfall protein. Biotechniques 2004; 36: 64-66.
95. Cavallone D, Malagolini N, Frasca GM, Stefoni S, Serafini-Cessi F: Salt-precipitation method does not isolate to homogeneity Tamm-Horsfall glycoprotein from urine of proteinuric patients and pregnant women. Clin Biochem 2002; 35: 405-410.
96. Dahan K, Devuyst O, Smaers M, Vertommen D, Loute G, Poux JM, Viron B, Jacquot C, Gagnadoux MF, Chauveau D, Buchler M, Cochat P, Cosyns JP, Mougenot B, Rider MH, Antignac C, Verellen-Dumoulin C, Pirson Y: A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol 2003; 14: 2883-2893.
97. Bleyer AJ, Hart TC, Shihabi Z, Robins V, Hoyer JR: Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein. Kidney Int 2004; 66: 974-977.
98. Vylet'al P, Kublova M, Kalbacova M, Hodanova K, Baresova V, Stiburkova B, Sikora J, Hulkova H, Zivny J, Majewski J, Simmonds A, Fryns JP, Venkat-Raman G, Elleder M, Kmoch S: Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int 2006; 70: 1155-1169.
99. Zimmerhackl LB, Pfleiderer S, Kinne R, Manz F, Schuler G, Brandis M: Tamm-Horsfall-Protein excretion as a marker of ascending limb transport indicates early renal tubular damage in diabetes mellitus type I. J Diabet Complications 1991; 5: 112-114.
100. Uto I, Ishimatsu T, Hirayama H, Ueda S, Tsuruta J, Kambara T: Determination of urinary Tamm-Horsfall protein by ELISA using a maleimide method for enzyme-antibody conjugation. J Immunol Methods 1991; 138: 87-94.
101. Kjellsson B, Soderstrom T, Hanson LA: An ELISA method for quantification of Tamm-Horsfall protein using monoclonal antibodies. J Immunol Methods 1987; 98: 105-111.
102. Hunt JS, Peach RJ, Brunisholz MC, Lynn KL, McGiven AR: A sensitive and specific ELISA using a monoclonal capture antibody for detection of Tamm-Horsfall urinary glycoprotein in serum. J Immunol Methods 1986; 91: 35-43.
103. Alfaham M, Peters TJ, Meyrick S, Avis P, Verrier Jones K: Serum Tamm-Horsfall protein levels in childhood: relationship with age and glomerular filtration rate. Nephron 1989; 52: 216-221.
104. Grant AM, Neuberger A: The development of a radioimmunoassay for the measurement of urinary Tamm-Horsfall glycoprotein in the presence of sodium dodecyl sulphate. Clin Sci 1973; 44: 163-179.
105. Avis PJ: The development of a radioimmunoassay procedure for the estimation of Tamm-Horsfall glycoprotein in human serum. Clin Sci Mol Med 1977; 52: 183-191.
106. Goodall AA, Marshall RD: Effects of freezing on the estimated amounts of Tamm-Horsfall glycoprotein in urine, as determined by radioimmunoassay. Biochem J 1980; 189: 533-539.
107. Lynn KL, Shenkin A, Marshall RD: Factors affecting excretion of human urinary Tamm-Horsfall glycoprotein. Clin Sci (Lond) 1982; 62: 21-26.
108. Yu M, Zhu YQ: Clinical significance of determination of urinary albumin, beta 2 microglobulin and Tamm-Horsfall protein in diabetics (in Chinese). Zhonghua Nei Ke Za Zhi 1991; 30: 354-356, 383.
109. Gambaro G, Baggio B, Favaro S, Cicerello E, Marchini F, Borsatti A: Role of Tamm-Horsfall mucoprotein in calcium oxalate lithogenesis (in French). Nephrologie 1984; 5: 171-172.
110. Haugen H, Akesson I, Enger E, Meberg A: Uromucoid in normal urine. Scand J Clin Lab Invest 1978; 38: 49-51.
111. Bichler KH, Kirchner C, Ideler V: Uromucoid excretion of normal individuals and stone formers. Br J Urol 1975; 47: 733-737.
112. Samuell CT: Uromucoid excretion in normal subjects, calcium stone formers and in patients with chronic renal failure. Urol Res 1979; 7: 5-12.
113. Shihabi ZK, Hinsdale ME, Bleyer AJ: Analysis of Tamm-Horsfall protein by high-performance liquid chromatography with native fluorescence. J Chromatogr A 2004; 1027: 161-166.
114. Yokomizo K, Iijima S, Sakai N, Kurihara Y, Hitratsuka N, Nagai K, Iwai T, Shiba K: Urinary protein analysis in pre-and postoperative cancer patients. J Clin Lab Anal 2005; 19: 253-259.
115. Wai-Hoe L, Wing-Seng L, Ismail Z, Lay-Harn G: SDS-PAGE-based quantitative assay for screening of kidney stone disease. Biol Proced Online 2009; 11: 145-160.
116. Pourmand G, Nasseh H, Sarrafnejad A, Mojtahedi A, Mehrsai A, Alamdari DH, Nourijelyani K: Comparison of urinary proteins in calcium stone formers and healthy individuals: a case-control study. Urol Int 2006; 76: 163-168.
117. Bernascone I, Vavassori S, Di Pentima A, Santambrogio S, Lamorte G, Amoroso A, Scolari F, Ghiggeri GM, Casari G, Polishchuk R, Rampoldi L: Defective intracellular trafficking of uromodulin mutant isoforms. Traffic 2006; 7: 1567-1579.
118. Dahan K, Fuchshuber A, Adamis S, Smaers M, Kroiss S, Loute G, Cosyns JP, Hildebrandt F, Verellen-Dumoulin C, Pirson Y: Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease? J Am Soc Nephrol 2001; 12: 2348-2357.
119. Bleyer AJ, Hart TC, Willingham MC, Iskandar SS, Gorry MC, Trachtman H: Clinico-pathologic findings in medullary cystic kidney disease type 2. Pediatr Nephrol 2005; 20: 824-827.
120. Choi SW, Ryu OH, Choi SJ, Song IS, Bleyer AJ, Hart TC: Mutant Tamm-Horsfall glycoprotein accumulation in endoplasmic reticulum induces apoptosis reversed by colchicine and sodium 4-phenylbutyrate. J Am Soc Nephrol 2005; 16: 3006-3014.
121. Paladino S, Pocard T, Catino MA, Zurzolo C: GPI-anchored proteins are directly targeted to the apical surface in fully polarized MDCK cells. J Cell Biol 2006; 172: 1023-1034.
122. Rajendran L, Simons K: Lipid rafts and membrane dynamics. J Cell Sci 2005; 118: 1099-1102.
123. Hoyer JR, Seiler MW: Pathophysiology of Tamm-Horsfall protein. Kidney Int 1979; 16: 279-289.
124. Sabharanjak S, Sharma P, Parton RG, Mayor S: GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell 2002; 2: 411-423.
125. Kirkham M, Fujita A, Chadda R, Nixon SJ, Kurzchalia TV, Sharma DK, Pagano RE, Hancock JF, Mayor S, Parton RG: Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. J Cell Biol 2005; 168: 465-476.
126. Zaucke F, Boehnlein JM, Steffens S, Polishchuk RS, Rampoldi L, Fischer A, Pasch A, Boehm CW, Baasner A, Attanasio M, Hoppe B, Hopfer H, Beck BB, Sayer JA, Hildebrandt F, Wolf MT: Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression. Hum Mol Genet 2010; 19: 1985-1997.
127. Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR: Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem 2001; 276: 9924-9930.
128. Orskov I, Ferencz A, Orskov F: Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli . Lancet 1980; 1: 887.
129. Parkkinen J, Virkola R, Korhonen TK: Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins. Infect Immun 1988; 56: 2623-2630.
130. Glauser A, Hochreiter W, Jaeger P, Hess B: Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.Nephrol Dial Transplant 2000; 15: 1580-1587.
131. Grover PK, Moritz RL, Simpson RJ, Ryall RL: Inhibition of growth and aggregation of calcium oxalate crystals in vitro - A comparison of four human proteins. Eur J Biochem 1998; 253: 637-644.
132. Hess B, Nakagawa Y, Coe FL: Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 1989; 257:F99-F106.
133. Worcester EM: Urinary calcium oxalate crystal growth inhibitors. J Am Soc Nephrol 1994; 5:S46-S53.
134. Beshensky AM, Wesson JA, Worcester EM, Sorokina EJ, Snyder CJ, Kleinman JG: Effects of urinary macromolecules on hydroxyapatite crystal formation. J Am Soc Nephrol 2001; 12: 2108-2116.
135. Kumar V, Farell G, Lieske JC: Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells. J Urol 2003; 170: 221-225.
136. Kumar V, Pena de la Vega L, Farell G, Lieske JC: Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers. Kidney Int 2005; 68: 1784-1792.
137. Gersch MS, Sautin YY, Gersch CM, Henderson G, Bankir L, Johnson RJ: Does Tamm-Horsfall protein-uric acid binding play a significant role in urate homeostasis? Nephrol Dial Transplant 2006; 21: 2938-2942.
138. Diamond HS, Paolino JS: Evidence for a postsecretory reabsorptive site for uric acid in man. J Clin Invest 1973; 52: 1491-1499.
139. Podevin R, Ardaillou R, Paillard F, Fontanelle J, Richet G: Study in man of the kinetics of the appearance of uric acid 2-14C in the urine (in French). Nephron 1968; 5: 134-140.
140. Podevin R, Paillard F, Hornych A, Ardaillou R, Fontanelle J, Richet G: Kinetics of the appearance in the urine of para-aminohippuric acid (PAH) and of 2-14C uric acid in man. Effects of benziodarone, acetylsalicylic acid and pyrazinamide (in French). Rev Fr Etud Clin Biol 1968; 13: 513-522.
141. Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, Hultgren SJ, Kumar S: Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 2004; 65: 791-797.
142. Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, Wu XR: Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli . Am J Physiol Renal Physiol 2004; 286:F795-F802.
143. Raffi HS, Bates JM Jr, Laszik Z, Kumar S: Tamm-Horsfall protein acts as a general host-defense factor against bacterial cystitis. Am J Nephrol 2005; 25: 570-578.
144. Raffi HS, Bates JM, Jr., Laszik Z, Kumar S: Tamm-Horsfall protein protects against urinary tract infection by proteus mirabilis. J Urol 2009; 181: 2332-2338.
145. Mo L, Huang HY, Zhu XH, Shapiro E, Hasty DL, Wu XR: Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 2004; 66: 1159-1166.
146. El-Achkar TM, Wu XR, Rauchman M, Mc-Cracken R, Kiefer S, Dagher PC: Tamm-Horsfall protein protects the kidney from ischemic injury by decreasing inflammation and altering TLR4 expression. Am J Physiol Renal Physiol 2008; 295:F534-F544.
147. Bachmann S, Mutig K, Bates J, Welker P, Geist B, Gross V, Luft FC, Alenina N, Bader M, Thiele BJ, Prasadan K, Raffi HS, Kumar S: Renal effects of Tamm-Horsfall protein (uromodulin) deficiency in mice. Am J Physiol Renal Physiol 2005; 288:F559-F567.
148. Gersch M, Mutig K, Bachmann S, Kumar S, Ouyang X, Johnson R: Is salt-wasting the long awaited answer to the hyperuricaemia seen in uromodulin storage diseases? Nephrol Dial Transplant 2006; 21: 2028-2029.
149. Dan T, Tanaka H, Koga H: Mechanism of uricosuric action of AA-193 in DBA/2N mice. J Pharmacol Exp Ther 1990; 253: 437-443.
150. Hoyer JR: Tubulointerstitial immune complex nephritis in rats immunized with Tamm-Horsfall protein. Kidney Int 1980; 17: 284-292.
151. Seiler MW, Hoyer JR: Ultrastructural studies of tubulointerstitial immune complex nephritis in rats immunized with Tamm-Horsfall protein. Lab Invest 1981; 45: 321-327.
152. Mayrer AR, Kashgarian M, Ruddle NH, Marier R, Hodson CJ, Richards FF, Andriole VT: Tubulointerstitial nephritis and immunologic responses to Tamm-Horsfall protein in rabbits challenged with homologous urine or Tamm-Horsfall protein. J Immunol 1982; 128: 2634-2642.
153. Sherblom AP, Decker JM, Muchmore AV: The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem 1988; 263: 5418-5424.
154. Rhodes DC, Hinsman EJ, Rhodes JA: Tamm-Horsfall glycoprotein binds IgG with high affinity. Kidney Int 1993; 44: 1014-1021.
155. Su SJ, Chang KL, Lin TM, Huang YH, Yeh TM: Uromodulin and Tamm-Horsfall protein induce human monocytes to secrete TNF and express tissue factor. J Immunol 1997; 158: 3449-3456.
156. Cavallone D, Malagolini N, Serafini-Cessi F: Binding of human neutrophils to cellsurface anchored Tamm-Horsfall glycoprotein in tubulointerstitial nephritis. Kidney Int 1999; 55: 1787-1799.
157. Ratliff TL: Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Urol 2005; 174: 1150.
158. Toma G, Bates JM, Jr., Kumar S: Uromodulin (Tamm-Horsfall protein) is a leukocyte adhesion molecule. Biochem Biophys Res Commun 1994; 200: 275-282.
159. Hession C, Decker JM, Sherblom AP, Kumar S, Yue CC, Mattaliano RJ, Tizard R, Kawashima E, Schmeissner U, Heletky S, et al: Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand for lymphokines. Science 1987; 237: 1479-1484.
160. Benetti E, Caridi G, Vella MD, Rampoldi L, Ghiggeri GM, Artifoni L, Murer L: Immature renal structures associated with a novel UMOD sequence variant. Am J Kidney Dis 2009; 53: 327-331.
161. Bleyer AJ, Trachtman H, Sandhu J, Gorry MC, Hart TC: Renal manifestations of a mutation in the uromodulin (Tamm Horsfall protein) gene. Am J Kidney Dis 2003; 42:E20-E26.
162. Calado J, Gaspar A, Clemente C, Rueff J: A novel heterozygous missense mutation in the UMOD gene responsible for familial juvenile hyperuricemic nephropathy. BMC Med Genet 2005; 6: 5.
163. Kudo E, Kamatani N, Tezuka O, Taniguchi A, Yamanaka H, Yabe S, Osabe D, Shinohara S, Nomura K, Segawa M, Miyamoto T, Moritani M, Kunika K, Itakura M: Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese families. Kidney Int 2004; 65: 1589-1597.
164. Lhotta K, Gehringer A, Jennings P, Kronenberg F, Brezinka C, Andersone I, Strazdins V: Familial juvenile hyperuricemic nephropathy: report on a new mutation and a pregnancy. Clin Nephrol 2009; 71: 80-83.
165. Nasr SH, Lucia JP, Galgano SJ, Markowitz GS, D'Agati VD: Uromodulin storage disease. Kidney Int 2008; 73: 971-976.
166. Williams SE, Reed AA, Galvanovskis J, Antignac C, Goodship T, Karet FE, Kotanko P, Lhotta K, Moriniere V, Williams P, Wong W, Rorsman P, Thakker RV: Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum. Hum Mol Genet 2009; 18: 2963-2974.
167. Wolf MT, Beck BB, Zaucke F, Kunze A, Misselwitz J, Ruley J, Ronda T, Fischer A, Eifinger F, Licht C, Otto E, Hoppe B, Hildebrandt F: The uromodulin C744G mutation causes MCKD2 and FJHN in children and adults and may be due to a possible founder effect. Kidney Int 2007; 71: 574-581.
168. Wolf MT, Mucha BE, Attanasio M, Zalewski I, Karle SM, Neumann HP, Rahman N, Bader B, Baldamus CA, Otto E, Witzgall R, Fuchshuber A, Hildebrandt F:
169. Stiburkova B, Majewski J, Sebesta I, Zhang W, Ott J, Kmoch S: Familial juvenile hyperuricemic nephropathy: localization of the gene on chromosome 16p11.2-and evidence for genetic heterogeneity. Am J Hum Genet 2000; 66: 1989-1994.
170. Auranen M, Ala-Mello S, Turunen JA, Jarvela I: Further evidence for linkage of autosomal-dominant medullary cystic kidney disease on chromosome 1q21. Kidney Int 2001; 60: 1225-1232.
171. Puig JG, Prior C, Martinez-Ara J, Torres RJ: Familial nephropathy associated with hyperuricemia in Spain: our experience with 3 families harbouring a UMOD mutation. Nucleosides Nucleotides Nucleic Acids 2006; 25: 1295-1300.
172. Stiburkova B, Majewski J, Hodanova K, Ondrova L, Jerabkova M, Zikanova M, Vylet'al P, Sebesta I, Marinaki A, Simmonds A, Matthijs G, Fryns JP, Torres R, Puig JG, Ott J, Kmoch S: Familial juvenile hyperuricaemic nephropathy (FJHN): linkage analysis in 15 families, physical and transcriptional characterisation of the FJHN critical region on chromosome 16p11.2 and the analysis of seven candidate genes. Eur J Hum Genet 2003; 11: 145-154.
173. Hodanova K, Majewski J, Kublova M, Vyletal P, Kalbacova M, Stiburkova B, Hulkova H, Chagnon YC, Lanouette CM, Marinaki A, Fryns JP, Venkat-Raman G, Kmoch S: Mapping of a new candidate locus for uromodulin-associated kidney disease (UAKD) to chromosome 1q41. Kidney Int 2005; 68: 1472-1482.
174. Zivna M, Hulkova H, Matignon M, Hodanova K, Vylet'al P, Kalbacova M, Baresova V, Sikora J, Blazkova H, Zivny J, Ivanek R, Stranecky V, Sovova J, Claes K, Lerut E, Fryns JP, Hart PS, Hart TC, Adams JN, Pawtowski A, Clemessy M, Gasc JM, Gubler MC, Antignac C, Elleder M, Kapp K, Grimbert P, Bleyer AJ, Kmoch S: Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Hum Genet 2009; 85: 204-213.
175. Bingham C, Ellard S, van't Hoff WG, Simmonds HA, Marinaki AM, Badman MK, Winocour PH, Stride A, Lockwood CR, Nicholls AJ, Owen KR, Spyer G, Pearson ER, Hattersley AT: Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutation. Kidney Int 2003; 63: 1645-1651.
176. Gresh L, Fischer E, Reimann A, Tanguy M, Garbay S, Shao X, Hiesberger T, Fiette L, Igarashi P, Yaniv M, Pontoglio M: A transcriptional network in polycystic kidney disease. EMBO J 2004; 23: 1657-1668.
177. Heidet L, Decramer S, Pawtowski A, Moriniere V, Bandin F, Knebelmann B, Lebre AS, Faguer S, Guigonis V, Antignac C, Salomon R: Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clin J Am Soc Nephrol 2010; 5: 1079-1090.
178. Takiue Y, Hosoyamada M, Yokoo T, Kimura M, Ochiai M, Kaneko K, Ichida K, Hosoya T, Shibasaki T: Production and characterization of transgenic mice harboring mutant human UMOD gene. Nucleosides Nucleotides Nucleic Acids 2008; 27: 596-600.
179. Takiue Y, Hosoyamada M, Yokoo T, Kimura M, Shibasaki T: Progressive accumulation of intrinsic mouse uromodulin in the kidneys of transgenic mice harboring the mutant human uromodulin gene. Biol Pharm Bull 2008; 31: 405-411.
180. Kemter E, Rathkolb B, Rozman J, Hans W, Schrewe A, Landbrecht C, Klaften M, Ivandic B, Fuchs H, Gailus-Durner V, Klingenspor M, de Angelis MH, Wolf E, Wanke R, Aigner B: Novel missense mutation of uromodulin in mice causes renal dysfunction with alterations in urea handling, energy, and bone metabolism. Am J Physiol Renal Physiol 2009; 297:F1391-F1398.
181. Bernascone I, Janas S, Ikehata M, Trudu M, Corbelli A, Schaeffer C, Rastaldi MP, Devuyst O, Rampoldi L: A transgenic mouse model for uromodulin-associated kidney diseases shows specific tubulo-interstitial damage, urinary concentrating defect and renal failure. Hum Mol Genet 2010; 19: 2998-3010.
182. Yusenko MV, Zubakov D, Kovacs G: Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours. Int J Biol Sci 2009; 5: 517-527.
183. Song X, Di Giovanni V, He N, Wang K, Ingram A, Rosenblum ND, Pei Y: Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 2009; 18: 2328-2343.
184. Stickel JS, Weinzierl AO, Hillen N, Drews O, Schuler MM, Hennenlotter J, Wernet D, Muller CA, Stenzl A, Rammensee HG, Stevanovic S: HLA ligand profiles of primary renal cell carcinoma maintained in metastases. Cancer Immunol Immunother 2009; 58: 1407-1417.
185. Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, Christman MF: Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer 2003; 3: 31.
186. Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA: Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 2005; 11: 5730-5739.
187. Kort EJ, Farber L, Tretiakova M, Petillo D, Furge KA, Yang XJ, Cornelius A, Teh BT: The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res 2008; 68: 4034-4038.
188. Cifola I, Spinelli R, Beltrame L, Peano C, Fasoli E, Ferrero S, Bosari S, Signorini S, Rocco F, Perego R, Proserpio V, Raimondo F, Mocarelli P, Battaglia C: Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol Cancer 2008; 7: 6.
189. Furge KA, Chen J, Koeman J, Swiatek P, Dykema K, Lucin K, Kahnoski R, Yang XJ, Teh BT: Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res 2007; 67: 3171-3176.
190. Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M, Brooks JD: Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 2003; 162: 925-932.
191. Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, Sun LZ, Ahlquist DA, Wood CG, Copland JA: Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.Clin Cancer Res 2007; 13: 4740-4749.
192. Boni JP, Leister C, Bender G, Fitzpatrick V, Twine N, Stover J, Dorner A, Immermann F, Burczynski ME: Population pharmacokinetics of CCI-779: correlations to safety and pharmacogenomic responses in patients with advanced renal cancer. Clin Pharmacol Ther 2005; 77: 76-89.
193. Austruy E, Cohen-Salmon M, Antignac C, Beroud C, Henry I, Nguyen VC, Brugieres L, Junien C, Jeanpierre C: Isolation of kidney complementary DNAs down-expressed in Wilms' tumor by a subtractive hybridization approach. Cancer Res 1993; 53: 2888-2894.
194. Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D'Agati V, Licht JD, Tycko B: CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors. Am J Pathol 2004; 165: 1943-1953.
195. Kumar S, Marsden HB, Jasani B, Kumar P: Study of childhood renal tumours using a monoclonal antibody to Tamm-Horsfall protein. J Clin Pathol 1987; 40: 1456-1462.
196. Saint-Mezard P, Berthier CC, Zhang H, Hertig A, Kaiser S, Schumacher M, Wieczorek G, Bigaud M, Kehren J, Rondeau E, Raulf F, Marti HP: Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Transpl Int 2009; 22: 293-302.
197. Rodder S, Scherer A, Raulf F, Berthier CC, Hertig A, Couzi L, Durrbach A, Rondeau E, Marti HP: Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. Am J Transplant 2009; 9: 517-526.
198. Park WD, Stegall MD: A meta-analysis of kidney microarray datasets: investigation of cytokine gene detection and correlation with rt-PCR and detection thresholds. BMC Genomics 2007; 8: 88.
199. Baelde HJ, Eikmans M, Doran PP, Lappin DW, de Heer E, Bruijn JA: Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 2004; 43: 636-650.
200. Cvoriscec D, Stavljenic A: Correlation between urinary excretion of Tamm-Horsfall protein and sodium chloride in endemic nephropathy. J Trace Elem Electrolytes Health Dis 1988; 2: 205-207.
201. Thornley C, Dawnay A, Cattell WR: Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay. Clin Sci (Lond) 1985; 68: 529-535.
202. Ying WZ, Sanders PW: Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats. Kidney Int 1998; 54: 1150-1156.
203. Mazzuchi N, Pecarovich R, Ross N, Rodriguez I, Sanguinetti CM: Tamm-Horsfall urinary glycoprotein quantitation by radial immunodiffusion: normal patterns. J Lab Clin Med 1974; 84: 771-776.
204. Ollier-Hartmann MP, Pouget-Abadie C, Bouillie J, Hartmann L: Variations of urinary Tamm-Horsfall protein in humans during the first thirty years of life. Nephron 1984; 38: 163-166.
205. McKenzie JK, Patel R, McQueen EG: The excretion rate of Tamm-Horsfall urinary mucoprotein in normals and in patients with renal disease. Australas Ann Med 1964; 13: 32-39.
206. Schwartz RH, Van Ess JD, May AG, Schenk EA, Freeman RB: Tamm-Horsfall glycoproteinuria and renal allograft rejection. Transplantation 1973; 16: 83-87.
207. Dulawa J, Kokot F, Kokot M, Pander H: Urinary excretion of Tamm-Horsfall protein in normotensive and hypertensive elderly patients. J Hum Hypertens 1998; 12: 635-637.
208. Sobel JD, Kaye D: Reduced uromucoid excretion in the elderly. J Infect Dis 1985; 152: 653.
209. Grant AM, Neuberger A: The turnover rate of rabbit urinary Tamm-Horsfall glycoprotein. Biochem J 1973; 136: 659-668.
210. Prajczer S, Heidenreich U, Pfaller W, Kotanko P, Lhotta K, Jennings P: Evidence for a role of uromodulin in chronic kidney disease progression. Nephrol Dial Transplant 2010; 25: 1896-1903.
211. Sejdiu I, Torffvit O: Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients. Scand J Urol Nephrol 2008; 42: 168-174.
212. Holmquist P, Torffvit O: Tubular function in diabetic children assessed by Tamm-Horsfall protein and glutathione S-transferase. Pediatr Nephrol 2008; 23: 1079-1083.
213. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith AV, O'Connell JR, Li M, Schmidt H, Tanaka T, Isaacs A, Ketkar S, Hwang SJ, Johnson AD, Dehghan A, Teumer A, Pare G, Atkinson EJ, Zeller T, Lohman K, Cornelis MC, Probst-Hensch NM, Kronenberg F, Tonjes A, Hayward C, Aspelund T, Eiriksdottir G, Launer LJ, Harris TB, Rampersaud E, Mitchell BD, Arking DE, Boerwinkle E, Struchalin M, Cavalieri M, Singleton A, Giallauria F, Metter J, de Boer IH, Haritunians T, Lumley T, Siscovick D, Psaty BM, Zillikens MC, Oostra BA, Feitosa M, Province M, de Andrade M, Turner ST, Schillert A, Ziegler A, Wild PS, Schnabel RB, Wilde S, Munzel TF, Leak TS, Illig T, Klopp N, Meisinger C, Wichmann HE, Koenig W, Zgaga L, Zemunik T, Kolcic I, Minelli C, Hu FB, Johansson A, Igl W, Zaboli G, Wild SH, Wright AF, Campbell H, Ellinghaus D, Schreiber S, Aulchenko YS, Felix JF, Rivadeneira F, Uitterlinden AG, Hofman A, Imboden M, Nitsch D, Brandstatter A, Kollerits B, Kedenko L, Magi R, Stumvoll M, Kovacs P, Boban M, Campbell S, Endlich K, Volzke H, Kroemer HK, Nauck M, Volker U, Polasek O, Vitart V, Badola S, Parker AN, Ridker PM, Kardia SL, Blankenberg S, Liu Y, Curhan GC, Franke A, Rochat T, Paulweber B, Prokopenko I, Wang W, Gudnason V, Shuldiner AR, Coresh J, Schmidt R, Ferrucci L, Shlipak MG, van Duijn CM, Borecki I, Kramer BK, Rudan I, Gyllensten U, Wilson JF, Witteman JC, Pramstaller PP, Rettig R, Hastie N, Chasman DI, Kao WH, Heid IM, Fox CS: New loci associated with kidney function and chronic kidney disease. Nat Genet 2010; 42: 376-384.
214. Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, Gale DP, Wass MN, Ahmadi KR, Bakker SJL, Beckmann J, Bilo HJG, Bochud M, Brown MJ, Caulfield MJ, Connell JMC, Cook HT, Cotlarciuc I, Smith GD, de Silva R, Deng G, Devuyst O, Dikkeschei LD, Dimkovic N, Dockrell M, Dominiczak A, Ebrahim S, Eggermann T, Farrall M, Ferrucci L, Floege J, Forouhi NG, Gansevoort RT, Han X, Hedblad B, van der Heide JJH, Hepkema BG, Hernandez-Fuentes M, Hypponen E, Johnson T, de Jong PE, Kleefstra N, Lagou V, Lapsley M, Li Y, Loos RJF, Luan Ja, Luttropp K, Marechal C, Melander O, Munroe PB, Nordfors L, Parsa A, Peltonen L, Penninx BW, Perucha E, Pouta A, Prokopenko I, Roderick PJ, Ruokonen A, Samani NJ, Sanna S, Schalling M, Schlessinger D, Schlieper G, Seelen MAJ, Shuldiner AR, Sjogren M, Smit JH, Snieder H, Soranzo N, Spector TD, Stenvinkel P, Sternberg MJE, Swaminathan R, Tanaka T, Ubink-Veltmaat LJ, Uda M, Vollenweider P, Wallace C, Waterworth D, Zerres K, Waeber G, Wareham NJ, Maxwell PH, McCarthy MI, Jarvelin M-R, Mooser V, Abecasis GR, Lightstone L, Scott J, Navis G, Elliott P, Kooner JS: Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 2010; 42: 373-375.
215. Pattaro C, De Grandi A, Vitart V, Hayward C, Franke A, Aulchenko YS, Johansson A, Wild SH, Melville SA, Isaacs A, Polasek O, Ellinghaus D, Kolcic I, Nothlings U, Zgaga L, Zemunik T, Gnewuch C, Schreiber S, Campbell S, Hastie N, Boban M, Meitinger T, Oostra BA, Riegler P, Minelli C, Wright AF, Campbell H, van Duijn CM, Gyllensten U, Wilson JF, Krawczak M, Rudan I, Pramstaller PP: A meta-analysis of genome-wide data from five European isolates reveals an association of COL22A1, SYT1, and GABRR2 with serum creatinine level. BMC Med Genet 2010; 11: 41.
216. Quintana LF, Sole-Gonzalez A, Kalko SG, Banon-Maneus E, Sole M, Diekmann F, Gutierrez-Dalmau A, Abian J, Campistol JM: Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol 2009; 20: 428-435.
217. Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, Seonarain M, Field E, Schatz CR, Estock MA, Ahmed N, Anderson NG, Steiner S: Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004; 4: 1159-1174.
218. Lau WH, Leong WS, Ismail Z, Gam LH: Qualification and application of an ELISA for the determination of Tamm Horsfall protein (THP) in human urine and its use for screening of kidney stone disease. Int J Biol Sci 2008; 4: 215-222.
219. Khan SR, Canales BK: Genetic basis of renal cellular dysfunction and the formation of kidney stones. Urol Res 2009; 37: 169-180.
220. Weaver ML, Qiu SR, Hoyer JR, Casey WH, Nancollas GH, De Yoreo JJ: Surface aggregation of urinary proteins and aspartic acidrich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy. Calcif Tissue Int 2009; 84: 462-473.
221. Kokot M, Dulawa J, Nowicki M, Kokot F, Machowska J: Urinary excretion of Tamm-Horsfall protein by patients with acute renal failure (in Polish). Pol Arch Med Wewn 1992; 88: 225-229.
222. Chen A, Zhao S, Huang S: Relationship between Syndrome-Type in TCM and four trace urinary proteins in patients with bronchial asthma (in Chinese). Zhongguo Zhong Xi Yi Jie He Za Zhi 1998; 18: 537-539.
223. Cvoriscec D, Stavljenic A, Radonic M: Tamm-Horsfall protein in Balkan endemic nephropathy. J Clin Chem Clin Biochem 1985; 23: 177-181.
224. Raicevic S, Trnacevic S, Hranisavljevic J, Vucelic D: Renal function, protein excretion, and pathology of Balkan endemic nephropathy. II. Protein excretion. Kidney Int Suppl 1991; 34:S52-S56.
225. Radonic M, Cvoriscec D, Borso G, Stavljenic A, Ceovic S: Tamm-Horsfall protein determination in Balkan endemic nephropathy. Urol Res 1988; 16: 377-380.
226. Cvoriscec D, Stavljenic A, Radonic M: Relationship between tubular and Tamm-Horsfall proteinuria in Balkan endemic nephropathy. Nephron 1986; 42: 152-155.
227. Yang HC: Monitoring of renal function in burn patients with radioimmunological evaluation (in Chinese). Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 1992; 8: 288-290, 330.
228. Grant AM, Baker LR, Neuberger A: Urinary Tamm-Horsfall glycoprotein in certain kidney diseases and its content in renal and bladder calculi. Clin Sci 1973; 44: 377-384.
229. Kido T, Honda R, Tsuritani I, Ishizaki M, Yamada Y, Nakagawa H, Nogawa K: Significant increase of urinary mucoprotein in environmental-cadmium-exposed Japanese subjects. Toxicol Lett 1991; 55: 303-309.
230. Jackle-Meyer I, Gwinner W, Baum M, Soose M, Petzoldt R, Schmoll HJ, Stolte H: Significance of Tamm-Horsfall protein excretion in diabetes mellitus and cisplatin nephrotoxicity. Contrib Nephrol 1990; 83: 124-129.
231. Zimmerhackl LB: Evaluation of nephrotoxicity with renal antigens in children: role of Tamm-Horsfall protein. Eur J Clin Pharmacol 1993; 44(Suppl 1):S39-S42.
232. MacLean FR, Skinner R, Hall AG, English M, Pearson AD: Acute changes in urine protein excretion may predict chronic ifosfamide nephrotoxicity: a preliminary observation. Cancer Chemother Pharmacol 1998; 41: 413-416.
233. Dawnay A, Lucey MR, Thornley C, Beetham R, Neuberger JM, Cattell WR, Williams R: The effects of long-term, lowdose cyclosporine A on renal tubular function in humans. Transplant Proc 1988; 20: 725-731.
234. Torffvit O, Jorgensen PE, Kamper AL, Holstein-Rathlou NH, Leyssac PP, Poulsen SS, Strandgaard S: Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy. Nephron 1998; 79: 167-172.
235. Holmquist P, Torffvit O, Jorgensen PE, Torring N, Nexo E, Sjoblad S: Early urinary changes in Tamm-Horsfall protein and epidermal growth factor in diabetic children. Pediatr Nephrol 2001; 16: 488-492.
236. Mattyus I, Miltenyi M, Zimmerhackl LB, Schwarz A, Hentschel M, Brandis M, Tulassay T: Endothelin excretion during ketoacidosis does not correlate with tubular dysfunction. Pediatr Nephrol 1994; 8: 304-308.
237. Torffvit O, Eriksson JW, Henricsson M, Sundkvist G, Arnqvist HJ, Blohme G, Bolinder J, Nystrom L, Ostman J, Svensson M: Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden. J Diabetes Complications 2007; 21: 246-251.
238. Torffvit O, Agardh CD, Thulin T: A study of Tamm-Horsfall protein excretion in hypertensive patients and type 1 diabetic patients. Scand J Urol Nephrol 1999; 33: 187-191. (Pubitemid 29356220)
239. Torffvit O, Agardh CD: Tubular secretion of Tamm-Horsfall protein is decreased in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. Nephron 1993; 65: 227-231.
240. Torffvit O: Urinary sulphated glycosaminoglycans and Tamm-Horsfall protein in type 1 diabetic patients. Scand J Urol Nephrol 1999; 33: 328-332. (Pubitemid 29500928)
241. Torffvit O, Agardh CD, Kjellsson B, Wieslander J: Tubular secretion of Tamm-Horsfall protein in type 1 (insulin-dependent) diabetes mellitus using a simplified enzyme linked immunoassay. Clin Chim Acta 1992; 205: 31-41.
242. Torffvit O, Agardh CD: Urinary excretion rate of NC1 and Tamm-Horsfall protein in the microalbuminuric type I diabetic patient. J Diabetes Complications 1994; 8: 77-83.
243. Pfleiderer S, Zimmerhackl LB, Kinne R, Manz F, Schuler G, Brandis M: Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall protein. Clin Investig 1993; 71: 972-977.
244. Catalano C, Torffvit O: Urinary excretion of Tamm-Horsfall protein in normotensive, normo-albuminuric type 1 diabetic patients. Nephron 1996; 72: 436-441. (Pubitemid 26059576)
245. Below AA, Chakraborty J, Khuder SH, Haselhuhn GD: Evaluation of urinary Tamm-Horsfall protein in post-menopausal diabetic women. J Diabetes Complications 1999; 13: 204-210.
246. Bernard AM, Ouled AA, Lauwerys RR, Lambert A, Vandeleene B: Pronounced decrease of Tamm-Horsfall proteinuria in diabetics. Clin Chem 1987; 33: 1264.
247. Reinhart HH, Obedeanu N, Robinson R, Korzeniowski O, Kaye D, Sobel JD: Urinary excretion of Tamm-Horsfall protein in elderly women. J Urol 1991; 146: 806-808.
248. Cutillas PR, Chalkley RJ, Hansen KC, Cramer R, Norden AG, Waterfield MD, Burlingame AL, Unwin RJ: The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am J Physiol Renal Physiol 2004; 287:F353-F364.
249. Vilasi A, Cutillas PR, Maher AD, Zirah SF, Capasso G, Norden AW, Holmes E, Nicholson JK, Unwin RJ: Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. Am J Physiol Renal Physiol 2007; 293:F456-F467.
250. Schroter J, Timmermans G, Seyberth HW, Greven J, Bachmann S: Marked reduction of Tamm-Horsfall protein synthesis in hyperprostaglandin E-syndrome. Kidney Int 1993; 44: 401-410.
251. Dulawa J, Kokot M, Kokot F: Effects of furosemide, propranolol and nifedipine on urinary excretion of Tamm-Horsfall protein in patients with arterial hypertension (in Polish). Pol Arch Med Wewn 1992; 88: 212-218.
252. Bade JJ, Marrink J, Karrenbeld A, van der Weele L, Mensink HJ: Increased urinary levels of Tamm-Horsfall glycoprotein suggest a systemic etiology of interstitial cystitis. J Urol 1996; 156: 943-946.
253. Canter MP, Graham CA, Heit MH, Blackwell LS, Wilkey DW, Klein JB, Merchant ML: Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects. Am J Obstet Gynecol 2008; 198: 553.e1-e6.
254. Dawnay AB, Thornley C, Nockler I, Webb JA, Cattell WR: Tamm-Horsfall glycoprotein excretion and aggregation during intravenous urography. Relevance to acute renal failure. Invest Radiol 1985; 20: 53-57.
255. Ehrlich R, Robins T, Jordaan E, Miller S, Mbuli S, Selby P, Wynchank S, Cantrell A, De Broe M, D'Haese P, Todd A, Landrigan P: Lead absorption and renal dysfunction in a South African battery factory. Occup Environ Med 1998; 55: 453-460.
256. Pergande M, Jung K, Precht S, Fels LM, Herbort C, Stolte H: Changed excretion of urinary proteins and enzymes by chronic exposure to lead. Nephrol Dial Transplant 1994; 9: 613-618.
257. Yokomizoi K, Nakayama A, Hokazono E, Ninomiya A, Miyake R, Hiratsuka N, Okuyama M, Kato Y, Kobayashi S, Ito Y, Shiba K: Analysis of proteins in urinary tract stones and urine of urolithic patients (in Japanese). Rinsho Byori 2005; 53: 1109-1115.
258. Singh P, Pendse A, Rajkiran, Rajkiran, Partani B: Diurnal variations and 24 hr urinary excretion of mucoprotein and Tamm-Horsfall protein in renal stone patients. Indian J Clin Biochem 1993; 8: 54-58.
259. Du?awa J, Drab M, Drobisz M, Kokot F: Urinary excretion of Tamm-Horsfall protein in healthy subjects and patients with renal disease. Nieren Hochdruckkrankheiten 1993; 22: 110-113.
260. Singhal GD, Singh DN, Gopal SC, Ambasta SS, Gupta RM: Urinary mucoprotein in pediatric urolithiasis. J Pediatr Surg 1987; 22: 218-222.
261. Wai-Hoe L, Wing-Seng L, Ismail Z, Lay-Harn G: Proteomics and detection of uromodulin in first-time renal calculi patients and recurrent renal calculi patients. Appl Biochem Biotechnol 2009; 159: 221-232.
262. Boyce WH, Swanson M: Biocolloids of urine in health and in calculous disease. II.Electrophoretic and biochemical studies of a mucoprotein insoluble in molar sodium chloride. J Clin Invest 1955; 34: 1581-1589.
263. Ganter K, Bongartz D, Hesse A: Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients. Urology 1999; 53: 492-495.
264. Laube N, Glatz S, Hesse A: The relation of urinary Tamm-Horsfall-protein on CaOxcrystallization under the scope of the Bonn-Risk-Index. Urol Res 2001; 29: 45-49.
265. Scurr DS, Latif AB, Sergeant V, Robertson WG: Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine. Proc Eur Dial Transplant Assoc 1983; 20: 440-444.
266. Baggio B, Gambaro G, Favaro S, Borsatti A, Pavanello L, Siviero B, Zacchello G, Rizzoni GF: Juvenile renal stone disease: a study of urinary promoting and inhibiting factors. J Urol 1983; 130: 1133-1135.
267. Sophasan S, Chatasingh S, Thanphaichitr P, Dhanamitta S: Tamm Horsfall mucoprotein in urine of potential bladder stone formers. J Urol 1980; 124: 522-524.
268. Bichler KH, Henzler B, Strohmaier WL, Stahl C, Korn S: The significance of citrate, uromucoid and GAG for diagnosis of renal tubular acidosis in patients with urinary calculi (in German). Urologe A 1995; 34: 437-443.
269. Romero MC, Nocera S, Nesse AB: Decreased Tamm-Horsfall protein in lithiasic patients. Clin Biochem 1997; 30: 63-67.
270. Jaggi M, Nakagawa Y, Zipperle L, Hess B: Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 2007; 35: 55-62.
271. Bichler K, Mittermüller B, Strohmaier WL, Feil G, Eipper E: Excretion of Tamm-Horsfall protein in patients with uric acid stones. Urol Int 1999; 62: 87-92.
272. Tsai CY, Wu TH, Yu CL, Lu JY, Tsai YY: Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron 2000; 85: 207-214.
273. Cardenas A, Roels H, Bernard AM, Barbon R, Buchet JP, Lauwerys RR, Rosello J, Hotter G, Mutti A, Franchini I, et al: Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med 1993; 50: 17-27. (Pubitemid 23030200)
274. Meberg A, Haugen H, Akesson I, Sande H: Uromucoid (Tamm-Horsfall's mucoprotein) in amniotic fluid and in urine in children. Nephron 1979; 23: 28-31.
275. Voss JU, Roller M, Brinkmann E, Mangelsdorf I: Nephrotoxicity of organic solvents: biomarkers for early detection. Int Arch Occup Environ Health 2005; 78: 475-485.
276. Bruning T, Thier R, Mann H, Melzer H, Brode P, Dallner G, Bolt HM: Pathological excretion patterns of urinary proteins in miners highly exposed to dinitrotoluene. J Occup Environ Med 2001; 43: 610-615.
277. Mutti A, Alinovi R, Bergamaschi E, Biagini C, Cavazzini S, Franchini I, Lauwerys RR, Bernard AM, Roels H, Gelpi E, et al: Nephropathies and exposure to perchloroethylene in dry-cleaners. Lancet 1992; 340: 189-193.
278. Jablonski K, Bauer A, Karolak A, Dobryszycka W: Urinary mucoprotein fractions and 17-ketosteroids in healthy women and in patients with the stein-leventhal syndrome. Arch Immunol Ther Exp (Warsz) 1969; 17: 253-260.
279. Nesselhut T, Rath W, Grunow E, Kaufholz G, Ostermai U, Cillien N, Kuhn W: The relationship between urinary Tamm-Horsfall glycoprotein excretion and urinary activity of glycosidases in normal pregnancy and pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1993; 48: 23-31.
280. Nesselhut T, Rath W, Weber MH, Kuhn W: Changes in Tamm-Horsfall protein excretion in the urine of patients with hypertension in pregnancy (in German). Klin Wochenschr 1989; 67(Suppl 17):11-13. (Pubitemid 19143679)
281. Franek E, Bar A, Kokot F, Dulawa J, Wiecek A, Kochanska-Dziurowicz A, Bar K, Szkodny A, Pawlowski W, Myrta J: Abnormal function of renal tubules in patients with simple renal cysts. Int Urol Nephrol 1995; 27: 679-685.
282. Lynn KL, Marshall RD: Excretion of Tamm-Horsfall glycoprotein in renal disease. Clin Nephrol 1984; 22: 253-257.
283. Nakagawa Y: Urinary Tamm-Horsfall glycoprotein in patients with various renal diseases. Nippon Jinzo Gakkai Shi 1987; 29: 529-534.
284. Shiba KS, Kanamori K, Harada T, Nakao M, Nakajima K, Kodaira T, Nakagawa H: A cause of discrepancy between values for urinary protein as assayed by the Coomassie Brilliant Blue G-250 method and the sulfosalicylic acid method. Clin Chem 1985; 31: 1215-1218.
285. Wikiera-Magott I, Hurkacz M, Kilis-Pstrusinska K, Zielinska M, Zwolinska D, Orzechowska-Juzwenko K: Evaluation of renal function in children undergoing surgery under general anaesthesia (in Polish). Pol Merkur Lekarski 2002; 13: 212-215.
286. Dehne MG, Sablotzki A, Muhling J, Papke G, Kuntzsch U, Hempelmann G: Acute kidney failure. Non-invasive diagnosis of acute kidney failure in operative intensive care patients (in German). Anaesthesist 1998; 47: 193-201.
287. Aregger F, Pilop C, Uehlinger DE, Brunisholz R, Carrel TP, Frey FJ, Frey BM: Urinary proteomics before and after extracorporeal circulation in patients with and without acute kidney injury. J Thorac Cardiovasc Surg 2010; 139: 692-700.
288. Dehne MG, Boldt J, Heise D, Sablotzki A, Hempelmann G: Tamm-Horsfall protein, alpha-1-and beta-2-microglobulin as kidney function markers in heart surgery (in German). Anaesthesist 1995; 44: 545-551.
289. Dehne MG, Sablotzki A, Muhling J, Dehne KL, Rohrig R, Hempelmann G: Renal effects of cardiopulmonary bypass in the elderly. Perfusion 2002; 17: 205-209.
290. Torffvit O, Kamper AL, Strandgaard S: Tamm-Horsfall protein in urine after uninephrectomy/ transplantation in kidney donors and their recipients. Scand J Urol Nephrol 1997; 31: 555-559.
291. Kaden J, Groth J, May G, Liedvogel B: Urinary Tamm-Horsfall protein as a marker of renal transplant function. Urol Res 1994; 22: 131-136.
292. McLaughlin PJ, Aikawa A, Davies HM, Ward RG, Bakran A, Sells RA, Johnson PM: Uromodulin levels are decreased in urine during acute tubular necrosis but not during immune rejection after renal transplantation. Clin Sci (Lond) 1993; 84: 243-246.
293. Patzer L, Hempel L, Ringelmann F, Misselwitz J, Fuchs D, Zintl F, Brandis M, deBroe ME, Zimmerhackl LB: Renal function after conditioning therapy for bone marrow transplantation in childhood. Med Pediatr Oncol 1997; 28: 274-283.
294. Franek E, Bar A, Kokot F, Dulawa J, Wiecek A, Kochanska-Dziurowicz A, Bar K, Szkodny A, Pawlowski W, Myrta J: Concentrations of B2-microglobulin and Tamm-Horsfall protein in cyst fluid and urinary excretion of these proteins in patients with simple renal cysts (in Polish). Pol Arch Med Wewn 1994; 92: 107-115.
295. Patzer L, Ringelmann F, Kentouche K, Fuchs D, Zintl F, Brandis M, Zimmerhackl LB, Misselwitz J: Renal function in longterm survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 2001; 27: 319-327.
296. Romero MC, Zanaro N, Gonzalez L, Trigo P, Imventarza O, Nesse A: Tamm-Horsfall protein excretion to predict the onset of renal insufficiency. Clin Biochem 2002; 35: 65-68.
297. Lose G, Sorensen K, Frandsen B, Nathan E: Excretion of urinary Tamm-Horsfall glycoprotein in girls with recurrent urinary tract infections. Urol Res 1987; 15: 249-250.
298. Reinhart HH, Spencer JR, Zaki NF, Sobel JD: Quantitation of urinary Tamm-Horsfall protein in children with urinary tract infection. Eur Urol 1992; 22: 194-199.
299. Reinhart H, Obedeanu N, Hooton T, Stamm W, Sobel J: Urinary excretion of Tamm-Horsfall protein in women with recurrent urinary tract infections. J Urol 1990; 144: 1185-1187.
300. Wolska-Duda I, Dulawa J, Kokot F: Urinary excretion of Tamm-Horsfall protein, albumin and beta-2 microglobulin in children with recurrent urinary tract infection (in Polish). Pol Merkur Lekarski 2001; 11: 36-39.
301. Israele V, Darabi A, McCracken GH Jr: The role of bacterial virulence factors and Tamm-Horsfall protein in the pathogenesis of Escherichia coli urinary tract infection in infants. Am J Dis Child 1987; 141: 1230-1234.